ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #471Top JournalHybrid

Jnci-Journal of the National Cancer Institute

Acronym:feedback
•
Abbreviation (ISO):J NATL CANCER I
•
Identifier (ISSN):0027-8874(Print)/1460-2105(Online)
•
Publisher:Oxford University Press
Former Names:
JNCI-J NATL CANCER I
Clarivate JCR Index Advisory: Name Changed (Active in JCR)
Clarivate IF (2026)
7.7↑ +0.5
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Jnci-Journal of the National Cancer Institute

WoS Q1
59141811.2201810.2201911.6202013.5202111.8202210.320239.920247.220257.72026
Annual Impact Factor Metric
Current (2026):7.7
Scopus SJR & RankScopus Q1
3.786
#471

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
403

403 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
198articles/year
35.29% Gold OA•94.56% Original Research

Aims & Scope

The Journal of the National Cancer Institute publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as one of the most-cited original-research cancer journals by the Institute of Scientific Information in its annual Journal Citation Reports.

Topics Covered (Recognized by AI)
MedicineBiologyGeneticsInternal MedicineOncology & Cancer ResearchChemistryBiochemistryPathologyOncologyImmunology
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank49/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank43/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF7.7
Articles / Year320
Total Citations146
2025
IF7.2
Articles / Year392
Total Citations1,222
2024
IF9.9
Articles / Year348
Total Citations3,448
2023
IF10.3
Articles / Year260
Total Citations4,613
2022
IF11.816
Articles / Year226
Total Citations5,485

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #471Scopus Q1SCImago Profile
Scopus Coverage:1940-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
3.786

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.51

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,468 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations4,608
3-Year Documents777
Citable Documents574

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)3

Citations in government and international policy documents

Female Author Rate51.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Jnci-Journal of the National Cancer Institute (acronym: feedback, abbr: J NATL CANCER I, ISSN: 0027-8874) is a peer-reviewed international scholarly journal in the field of Medicine, published by Oxford University Press in United States. The periodical holds a Journal Impact Factor (JIF) of 7.70, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.786 (Q1), an H-index of 403.

The journal enforces rigorous peer evaluation with a publication frequency of Semimonthly, an annual output of approximately 198 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,468 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Oxford University Press
Publication Language
English
Frequency
Semimonthly
Indexing & Databases
SCIEScopusPubMed
Editorial Address
OXFORD UNIV PRESS INC, JOURNALS DEPT, 2001 EVANS RD, CARY, USA, NC, 27513

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 3d559195-180f-4751-aa20-e64aaa878752
Database Updated: 2026-09-28